In conclusion, our data for the first time demonstrated that levels of fMet are elevated in the circulation of SSc patients and implicate an important role for the mitochondrial component fMet in promoting neutrophil-mediated activation through FPR1 in SSc. The gene discussed is FPR1; the disease is systemic sclerosis.